These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1478300)
41. Peritoneovenous shunt (PVS) for malignant ascites. An analysis of outcome. Smith DA; Weaver DW; Bouwman DL Am Surg; 1989 Jul; 55(7):445-9. PubMed ID: 2742227 [TBL] [Abstract][Full Text] [Related]
42. [The clinical picture and therapy of malignant pleural mesothelioma]. Schiebe M; Hoffmann W; Kortmann RD; Bamberg M Strahlenther Onkol; 1994 Nov; 170(11):628-35. PubMed ID: 7526476 [TBL] [Abstract][Full Text] [Related]
43. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762 [TBL] [Abstract][Full Text] [Related]
45. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis. Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696 [TBL] [Abstract][Full Text] [Related]
46. [Metastatic seeding by pleural biopsy]. Blanchette G; Maunier N; Provost G Union Med Can; 1973 Feb; 102(2):330-4. PubMed ID: 4709466 [No Abstract] [Full Text] [Related]
47. Malignant Peritoneal Mesothelioma Arising in Young Adults With Long-standing Indwelling Intra-abdominal Shunt Catheters. Mujahed T; Tazelaar HD; Sukov WR; Halling KC; Davila JI; Glass C; Pavlisko EN; Strickland KC; Roggli V; Haque M; Mneimneh W; Carter E; Galateau-Salle F; Glidden D; Garcia-Kennedy R; Larsen BT Am J Surg Pathol; 2021 Feb; 45(2):255-262. PubMed ID: 32826527 [TBL] [Abstract][Full Text] [Related]
48. To seed or not to seed: the open question of mesothelioma intervention tract metastases. Bertolaccini L; Viti A; Terzi A Chest; 2014 Sep; 146(3):e111. PubMed ID: 25180738 [No Abstract] [Full Text] [Related]
49. A peritoneovenous shunt with an access port enables non surgical reversal of intraperitoneal catheter occlusion. Wigness BD; Rohde TD; Dorman FD; Rose R; Buchwald H ASAIO J; 1994; 40(3):M580-3. PubMed ID: 8555581 [TBL] [Abstract][Full Text] [Related]
50. Response. Thomas R; Lee YCG Chest; 2014 Sep; 146(3):e111-e112. PubMed ID: 25180739 [No Abstract] [Full Text] [Related]
51. Safety, feasibility and therapeutic activity of intrapleural autologous lymphocyte conditioned medium followed by systemic recombinant interleukin-2 and interferon-alpha in a patient with malignant pleural mesothelioma. Duensing S; Hamm H; Ganser A; Atzpodien J Cancer Biother Radiopharm; 1997 Jun; 12(3):141-2. PubMed ID: 10851459 [No Abstract] [Full Text] [Related]
52. [Zosteriform cutaneous metastases of malignant pleural mesothelioma]. Monteagudo Sánchez B; Cabanillas González M; Pérez Fernández A; de la Cámara Gómez J; Campo Cerecedo F Rev Clin Esp; 2009 May; 209(5):262-3. PubMed ID: 19480791 [No Abstract] [Full Text] [Related]
53. LeVeen shunt with wandering tip. Bourlière M; Pol B; Antoni M; Maillot A; Botta-Fridlund D; Le Treut YP; Gauthier AP Lancet; 1991 Oct; 338(8773):1012. PubMed ID: 1681314 [No Abstract] [Full Text] [Related]
54. Percutaneous placement and management of peritoneovenous shunts. Martin LG Semin Intervent Radiol; 2012 Jun; 29(2):129-34. PubMed ID: 23729983 [TBL] [Abstract][Full Text] [Related]
55. The use of double valve Denver peritoneal venous shunt for malignant ascites. Li MK; Shiu W; Li AK Ann Acad Med Singap; 1988 Jan; 17(1):129-31. PubMed ID: 2461140 [TBL] [Abstract][Full Text] [Related]
56. Development of tumor along the track of a peritoneovenous shunt. Khoury GG; Webster DJ; Keen CW Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1237. PubMed ID: 6424808 [No Abstract] [Full Text] [Related]